CMC(SH:600327) Shen Zhen Shang Bao·2025-11-24 15:46Core Viewpoint - The company is divesting its 80% stake in Jinhua Lianji Hospital for 1 yuan and transferring its debt of approximately 89.99 million yuan for 5.8 million yuan to optimize its healthcare service business and improve asset structure [1][2]. Group 1: Transaction Details - The company’s subsidiary, Junyao Medical, will transfer its 80% stake in Jinhua Lianji Hospital to Jinhua Lintian Biotechnology Co., Ltd. for 1 yuan [1]. - The debt owed to Junyao Medical by Jinhua Lianji, amounting to approximately 89.99 million yuan, will be transferred for 580,000 yuan [1]. - Since its acquisition in March 2022, Jinhua Lianji Hospital has incurred cumulative losses of 79.15 million yuan [1]. Group 2: Financial Impact - The transaction is expected to reduce the company's consolidated net profit attributable to shareholders by 34.25 million yuan in 2025 [2]. - The company reported a total revenue of 2.645 billion yuan for the first three quarters of 2025, a year-on-year decrease of 4.23% [2]. - The net profit attributable to shareholders for the same period was 55.66 million yuan, down 33.12% year-on-year [2]. Group 3: Company Background - The company, founded in 1988, is a leading commercial retail service enterprise in Wuxi and became the first commercial retail company listed in Jiangsu Province in 2002 [2]. - It is a member of the Junyao Group and serves as the main entity for the modern consumption sector of the group [2]. - After the divestment of Jinhua Lianji, the company still holds assets in the healthcare sector, including Junyao Pediatrics and Yaan Health, but is currently focusing on cost reduction and strategic restructuring [2].